Halozyme to Report First Quarter 2025 Financial and Operating Results
Go back to Halozyme to Report First Quarter 2025 Financial and Operating Results| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 107.00 -0.39 (0.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $107.39 | 52 Week High | $18.39 | |||
| Open | $106.93 | 52 Week Low | $6.96 | |||
| Day High | $107.95 | P/E | N/A | |||
| Day Low | $106.36 | EPS | $-0.58 | |||
| Volume | 1,487,905 | |||||
